These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

924 related items for PubMed ID: 29975331

  • 1. Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage After Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway.
    Liu J, Zhang S, Fan X, Yuan F, Dai J, Hu J.
    Spine (Phila Pa 1976); 2019 Jan 15; 44(2):E74-E81. PubMed ID: 29975331
    [Abstract] [Full Text] [Related]

  • 2. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
    Zhai Y, Zhu Y, Liu J, Xie K, Yu J, Yu L, Deng H.
    Med Sci Monit; 2020 Jan 08; 26():e918617. PubMed ID: 31912804
    [Abstract] [Full Text] [Related]

  • 3. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway.
    Zhang JJ, Peng K, Zhang J, Meng XW, Ji FH.
    PLoS One; 2017 Jan 08; 12(2):e0172006. PubMed ID: 28222157
    [Abstract] [Full Text] [Related]

  • 4. Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor κB signalling pathway.
    Yang YF, Peng K, Liu H, Meng XW, Zhang JJ, Ji FH.
    Clin Exp Pharmacol Physiol; 2017 Mar 08; 44(3):353-361. PubMed ID: 27998004
    [Abstract] [Full Text] [Related]

  • 5. Dexmedetomidine attenuates spinal cord ischemia-reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits.
    Sun Z, Zhao T, Lv S, Gao Y, Masters J, Weng H.
    J Transl Med; 2018 Jul 21; 16(1):209. PubMed ID: 30031397
    [Abstract] [Full Text] [Related]

  • 6. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway.
    Xue BB, Chen BH, Tang YN, Weng CW, Lin LN.
    Kaohsiung J Med Sci; 2019 Nov 21; 35(11):672-678. PubMed ID: 31373750
    [Abstract] [Full Text] [Related]

  • 7. MiR-27a ameliorates inflammatory damage to the blood-spinal cord barrier after spinal cord ischemia: reperfusion injury in rats by downregulating TICAM-2 of the TLR4 signaling pathway.
    Li XQ, Lv HW, Wang ZL, Tan WF, Fang B, Ma H.
    J Neuroinflammation; 2015 Feb 07; 12():25. PubMed ID: 25876455
    [Abstract] [Full Text] [Related]

  • 8. Exogenous activation of cannabinoid-2 receptor modulates TLR4/MMP9 expression in a spinal cord ischemia reperfusion rat model.
    Jing N, Fang B, Li Z, Tian A.
    J Neuroinflammation; 2020 Apr 06; 17(1):101. PubMed ID: 32248810
    [Abstract] [Full Text] [Related]

  • 9. Dexmedetomidine Attenuates Myocardial Injury Induced by Renal Ischemia/Reperfusion by Inhibiting the HMGB1-TLR4-MyD88-NF-κB Signaling Pathway.
    Zhang B, Zhang J, Ainiwaer Y, He B, Geng Q, Lin L, Li X.
    Ann Clin Lab Sci; 2021 May 06; 51(3):376-384. PubMed ID: 34162568
    [Abstract] [Full Text] [Related]

  • 10. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
    Yang J, Wu Y, Xu Y, Jia J, Xi W, Deng H, Tu W.
    J Surg Res; 2021 Apr 06; 260():350-358. PubMed ID: 33383282
    [Abstract] [Full Text] [Related]

  • 11. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
    Wang Y, Wu S, Yu X, Zhou S, Ge M, Chi X, Cai J.
    Int J Mol Sci; 2016 Jun 23; 17(7):. PubMed ID: 27347929
    [Abstract] [Full Text] [Related]

  • 12. TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury.
    Wang J, He GZ, Wang YK, Zhu QK, Chen W, Guo T.
    World J Gastroenterol; 2015 Jul 21; 21(27):8314-25. PubMed ID: 26217083
    [Abstract] [Full Text] [Related]

  • 13. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L, Li L, Lu S, Li K, Su Z, Wang Y, Fan X, Li X, Zhao G.
    Mol Immunol; 2018 Feb 21; 94():7-17. PubMed ID: 29241031
    [Abstract] [Full Text] [Related]

  • 14. Intrathecal antagonism of microglial TLR4 reduces inflammatory damage to blood-spinal cord barrier following ischemia/reperfusion injury in rats.
    Li XQ, Wang J, Fang B, Tan WF, Ma H.
    Mol Brain; 2014 Apr 21; 7():28. PubMed ID: 24751148
    [Abstract] [Full Text] [Related]

  • 15. The Pathway of Let-7a-1/2-3p and HMGB1 Mediated Dexmedetomidine Inhibiting Microglia Activation in Spinal Cord Ischemia-Reperfusion Injury Mice.
    Ha Sen Ta Na, Nuo M, Meng QT, Xia ZY.
    J Mol Neurosci; 2019 Sep 21; 69(1):106-114. PubMed ID: 31190218
    [Abstract] [Full Text] [Related]

  • 16. Dexmedetomidine Preconditioning Protects Rats from Renal Ischemia-Reperfusion Injury Accompanied with Biphasic Changes of Nuclear Factor-Kappa B Signaling.
    Bao N, Tang B, Wang J.
    J Immunol Res; 2020 Sep 21; 2020():3230490. PubMed ID: 32377532
    [Abstract] [Full Text] [Related]

  • 17. Fluvastatin attenuated ischemia/reperfusion-induced autophagy and apoptosis in cardiomyocytes through down-regulation HMGB1/TLR4 signaling pathway.
    Ding HS, Yang J, Yang J, Guo X, Tang YH, Huang Y, Chen Z, Fan ZX, Huang CX.
    Mol Biol Rep; 2021 May 21; 48(5):3893-3901. PubMed ID: 34032975
    [Abstract] [Full Text] [Related]

  • 18. Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia-reperfusion by inhibiting HMGB1 and the TLR3-cytokine pathway.
    Li XQ, Chen FS, Tan WF, Fang B, Zhang ZL, Ma H.
    J Neuroinflammation; 2017 Oct 23; 14(1):205. PubMed ID: 29061187
    [Abstract] [Full Text] [Related]

  • 19. Dexmedetomidine Alleviates CCI-Induced Neuropathic Pain via Inhibiting HMGB1-Mediated Astrocyte Activation and the TLR4/NF-κB Signaling Pathway in Rats.
    Zhao E, Bai L, Li S, Li L, Dou Z, Huang Y, Li Y, Lv Y.
    Neurotox Res; 2020 Oct 23; 38(3):723-732. PubMed ID: 32607919
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.